Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Depression pharmacogenomics

Roberts RL, Joyce PR, Mulder RT, Begg EJ, Kennedy MA. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. Pharmacogenomics J 2002 2 191-196. [Pg.144]

Lee, H.-J., Cha, J.-H., Ham, B.-J. etal. (2004). Association between a G-protein boldbeta3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J., 4, 29-33. [Pg.167]

Research underway by our group and others on the clinical pharmacogenomics of depression is focused on identifying genetic markers as positive and negative predictors of treatment response. It is necessary that rigorous clinical studies be performed in order to examine closely the relation between genotype and the phe-... [Pg.387]

Pharmacogenomics may be beneficial to people of color because of their high rates of morbidity and mortality from certain cancers, hypertension, cardiovascular disease, asthma, HIV /AIDS, Alzheimer disease, clinical depression, and other diseases. Thus more effective therapies help those individuals most in need of treatment. [Pg.282]

Cacabelos, R. (2007) Molecular pathology and pharmacogenomics in Alzheimer s disease Polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression. Meth. Find. Exper. Clin. Pharmacol., 29(suppl. B), 1-91. [Pg.328]

Barrero FJ, Ampuero I, Morales B et al (2005) Depression in Parkinson s disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J 5 135-141... [Pg.235]

Hall-Flavin DK, Winner JG, Allen JD, Jordan JJ, Nesheim RS, Snyder KA et al (2012) Using a pharmacogenomic algorithm to guide the treatment of depression. Transl Psychiatry 2 el72... [Pg.587]

Hong CJ, Chen TJ, Yu YW, et al. Response to fluoxetine and serotonin lA receptor (C1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 2006 6(l) 27-33. [Pg.156]

See other pages where Depression pharmacogenomics is mentioned: [Pg.394]    [Pg.394]    [Pg.81]    [Pg.379]    [Pg.379]    [Pg.380]    [Pg.380]    [Pg.382]    [Pg.384]    [Pg.386]    [Pg.386]    [Pg.387]    [Pg.387]    [Pg.388]    [Pg.390]    [Pg.391]    [Pg.392]    [Pg.392]    [Pg.394]    [Pg.412]    [Pg.575]    [Pg.575]    [Pg.575]    [Pg.130]    [Pg.233]    [Pg.211]    [Pg.101]    [Pg.148]    [Pg.299]    [Pg.130]    [Pg.131]    [Pg.527]    [Pg.130]    [Pg.131]    [Pg.36]    [Pg.181]   
See also in sourсe #XX -- [ Pg.387 ]

See also in sourсe #XX -- [ Pg.130 , Pg.131 ]



SEARCH



Pharmacogenomic

Pharmacogenomics

© 2024 chempedia.info